AI assistant
Sending…
Vanda Pharmaceuticals Inc. — Director's Dealing 2015
Jun 23, 2015
33390_dirs_2015-06-22_9de38740-6046-4415-8a95-b61d72fc9391.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2015-06-18
Reporting Person: PIEN HOWARD H (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-18 | Stock Option (Right to Buy) | $13.03 | A | 15000 | Acquired | 2025-06-17 | Common Stock (15000) | Direct |
Footnotes
F1: Option granted upon conclusion of annual meeting of stockholders pursuant to the provisions of the Issuer's 2006 Equity Incentive Plan providing for annual option grants for outside directors.
F2: Exercisable in equal monthly installments over 12 months starting one month after the grant date, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.
More from Vanda Pharmaceuticals Inc.
Regulatory Filings
2026
Jun 5
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19